Market validation
Test the market before you commit to it
China market validation for IP-driven SMEs considering China entry
China market validation tests whether the conditions for a successful entry actually exist. Most China entry decisions are made incorrectly because the decision is made on assumed rather than validated demand.
Getting that wrong is expensive and slow to reverse: Validation that confirms your assumptions costs weeks, but entry on wrong assumptions costs capital, structure, and time.
What is China market validation
Validation tests whether successful entry is possible
What it tests
Demand, partner capability, and commercial feasibility.
When it is done
It is run before investing capital beyond what the validation itself requires, and before allocating significant internal resource to China expansion.
What it produces
The output is a structured evidence set and a go/no-go decision brief - not a market research report.
Who this is relevant for
China market validation is designed for companies with a proven product or service in their home market, and actively considering whether China is the right next move:
SMEs with established commercial traction at home and a defined target segment in China.
Companies that have received inbound interest from a Chinese distributor or partner but cannot verify the quality of that interest without in-market assessment.
Businesses considering a WFOE or joint venture and wanting to know whether the commercial case supports the capital requirement.
Founders or commercial directors who have been to China, seen the opportunity, and want to test whether it is real before committing budget and management time.
Companies that have previously attempted China entry and want to approach a second attempt with a structured evidence base rather than revised optimism.
Companies under board or competitor pressure to enter China and needing evidence before they commit.
What validation tests
Three major conditions
Companies typically arrive in China with evidence of interest - inbound enquiries, trade fair conversations, distributor enthusiasm. That evidence is real. But it rarely maps to verified purchasing intent at viable commercial volumes. What appears to be market demand is frequently category curiosity: interest in the product that does not convert into buying behaviour at the price point the commercial model requires.
The diagnostic question
Can we identify an interest that is commercially actionable at the price point and volume your model requires
The Shaeps validation process
The output is a decision brief, not a market report
Scoping
We describe what the business model would look like - what demand signal would be sufficient, what partner profile is required, what commercial model needs to be demonstrated.
Evidence collection
Output: structured evidence set
Evidence is gathered through direct in-market engagement - channel conversations, partner assessments, regulatory mapping, and where possible, commercial signal testing.
Go/no-go decision
Output: decision brief
The evidence is structured into a clear recommendation: go, no-go, or conditional go. Without a structured decision brief, companies in attractive markets tend to proceed regardless of mixed signals.
Validation comes before entry: It determines whether entry should proceed at all, and it shapes the strategy that follows. Without a validated case, an entry strategy is premature. The right entry decision comes after validation.
No cure, no pay
We earn only on commercial outcomes. If the evidence does not support entry, we will say so
